Xvivo Perfusion AB (publ)

Informe acción OM:XVIVO

Capitalización de mercado: kr11.8b

Xvivo Perfusion Dirección

Dirección controles de criterios 3/4

El CEO de Xvivo Perfusion's es Christoffer Rosenblad, nombrado en Jan 2022, tiene una permanencia de 2.25 años. posee directamente un 0.18% de las acciones de la empresa, con un valor de SEK20.50M. La antigüedad media del equipo directivo y de la junta directiva es de 3.4 años y 3.5 años, respectivamente.

Información clave

Christoffer Rosenblad

Chief Executive Officer (CEO)

kr5.0m

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO2.3yrs
Participación del CEO0.2%
Permanencia media de la dirección3.5yrs
Promedio de permanencia en la Junta Directiva3.6yrs

Actualizaciones recientes de la dirección

Recent updates

Xvivo Perfusion AB (publ) (STO:XVIVO) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected

Apr 25
Xvivo Perfusion AB (publ) (STO:XVIVO) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected

There Are Reasons To Feel Uneasy About Xvivo Perfusion's (STO:XVIVO) Returns On Capital

Apr 11
There Are Reasons To Feel Uneasy About Xvivo Perfusion's (STO:XVIVO) Returns On Capital

Need To Know: Analysts Just Made A Substantial Cut To Their Xvivo Perfusion AB (publ) (STO:XVIVO) Estimates

Feb 05
Need To Know: Analysts Just Made A Substantial Cut To Their Xvivo Perfusion AB (publ) (STO:XVIVO) Estimates

We Think That There Are Issues Underlying Xvivo Perfusion's (STO:XVIVO) Earnings

Feb 01
We Think That There Are Issues Underlying Xvivo Perfusion's (STO:XVIVO) Earnings

Earnings Beat: Xvivo Perfusion AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jan 28
Earnings Beat: Xvivo Perfusion AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Returns On Capital At Xvivo Perfusion (STO:XVIVO) Have Stalled

Aug 24
Returns On Capital At Xvivo Perfusion (STO:XVIVO) Have Stalled

Why Xvivo Perfusion AB (publ) (STO:XVIVO) Could Be Worth Watching

Jul 17
Why Xvivo Perfusion AB (publ) (STO:XVIVO) Could Be Worth Watching

Do Xvivo Perfusion's (STO:XVIVO) Earnings Warrant Your Attention?

Jun 16
Do Xvivo Perfusion's (STO:XVIVO) Earnings Warrant Your Attention?

Xvivo Perfusion (STO:XVIVO) May Have Issues Allocating Its Capital

Apr 19
Xvivo Perfusion (STO:XVIVO) May Have Issues Allocating Its Capital

Are Investors Undervaluing Xvivo Perfusion AB (publ) (STO:XVIVO) By 21%?

Mar 23
Are Investors Undervaluing Xvivo Perfusion AB (publ) (STO:XVIVO) By 21%?

With EPS Growth And More, Xvivo Perfusion (STO:XVIVO) Makes An Interesting Case

Mar 07
With EPS Growth And More, Xvivo Perfusion (STO:XVIVO) Makes An Interesting Case

When Should You Buy Xvivo Perfusion AB (publ) (STO:XVIVO)?

Feb 13
When Should You Buy Xvivo Perfusion AB (publ) (STO:XVIVO)?

Be Wary Of Xvivo Perfusion (STO:XVIVO) And Its Returns On Capital

Dec 14
Be Wary Of Xvivo Perfusion (STO:XVIVO) And Its Returns On Capital

Is There An Opportunity With Xvivo Perfusion AB (publ)'s (STO:XVIVO) 35% Undervaluation?

Nov 17
Is There An Opportunity With Xvivo Perfusion AB (publ)'s (STO:XVIVO) 35% Undervaluation?

Xvivo Perfusion (STO:XVIVO) Might Be Having Difficulty Using Its Capital Effectively

Aug 20
Xvivo Perfusion (STO:XVIVO) Might Be Having Difficulty Using Its Capital Effectively

Statutory Profit Doesn't Reflect How Good Xvivo Perfusion's (STO:XVIVO) Earnings Are

Jul 21
Statutory Profit Doesn't Reflect How Good Xvivo Perfusion's (STO:XVIVO) Earnings Are

Be Wary Of Xvivo Perfusion (STO:XVIVO) And Its Returns On Capital

Mar 30
Be Wary Of Xvivo Perfusion (STO:XVIVO) And Its Returns On Capital

At kr258, Is Xvivo Perfusion AB (publ) (STO:XVIVO) Worth Looking At Closely?

Feb 18
At kr258, Is Xvivo Perfusion AB (publ) (STO:XVIVO) Worth Looking At Closely?

A Look At The Fair Value Of Xvivo Perfusion AB (publ) (STO:XVIVO)

Jan 30
A Look At The Fair Value Of Xvivo Perfusion AB (publ) (STO:XVIVO)

Calculating The Intrinsic Value Of Xvivo Perfusion AB (publ) (STO:XVIVO)

Apr 09
Calculating The Intrinsic Value Of Xvivo Perfusion AB (publ) (STO:XVIVO)

Should You Think About Buying Xvivo Perfusion AB (publ) (STO:XVIVO) Now?

Mar 19
Should You Think About Buying Xvivo Perfusion AB (publ) (STO:XVIVO) Now?

What Type Of Shareholders Own The Most Number of Xvivo Perfusion AB (publ) (STO:XVIVO) Shares?

Feb 26
What Type Of Shareholders Own The Most Number of Xvivo Perfusion AB (publ) (STO:XVIVO) Shares?

Have Insiders Been Buying Xvivo Perfusion AB (publ) (STO:XVIVO) Shares?

Feb 05
Have Insiders Been Buying Xvivo Perfusion AB (publ) (STO:XVIVO) Shares?

CEO

Christoffer Rosenblad (48 yo)

2.3yrs

Permanencia

kr5,031,000

Compensación

Mr. Christoffer Rosenblad serves as Chief Executive Officer at Xvivo Perfusion AB (publ) since November 30, 2022. He served as Deputy Chief Executive Officer and Global Business Development & Service Direc...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Christoffer Rosenblad
Chief Executive Officer2.3yrskr5.03m0.18%
SEK 20.9m
Kristoffer Nordstrom
CFO & Investor Relation3.5yrssin datos0.0085%
SEK 1.0m
Lena Hagman
Chief Operating Officer1.4yrssin datos0.0063%
SEK 752.1k
Ylva Vihoj
Global Human Resources Director1.3yrssin datossin datos
Magnus Nilsson
Senior Advisor3.9yrskr1.62msin datos
Andreas Wallinder
Chief Medical Officer3.7yrssin datos0.011%
SEK 1.3m
Johan Holmstrom
Chief Commercial Officer3.7yrssin datos0.012%
SEK 1.4m

3.5yrs

Permanencia media

53yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de XVIVO se considera experimentado (3.4 años antigüedad media).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Gosta Johannesson
Chairman of the Board11.3yrskr440.00k0.015%
SEK 1.8m
Lars Henriksson
Independent Director3.6yrssin datos0.0060%
SEK 714.2k
Erik Stromqvist
Independent Director1.1yrssin datos0.18%
SEK 20.9m
Camilla Oberg
Independent Director8yrskr130.00k0.0034%
SEK 405.1k
Lena Hoglund
Independent Director3.6yrssin datos0.0041%
SEK 489.1k
Goran Dellgren
Independent Director2.1yrssin datossin datos

3.6yrs

Permanencia media

62.5yo

Promedio de edad

Junta con experiencia: La junta directiva de XVIVO se considera experimentada (3.5 años de antigüedad promedio).